Emerging Trends Shaping the Healthcare Ecosystem in the Middle East and North Africa Region

Author(s)

Daccache C1, Karam R2, Elmahdawy M3, Akhras K4
1Maastricht University, Maastricht, Netherlands, 2Lebanese University, BEIRUT, BA, Lebanon, 3Novartis, Basel, Switzerland, 4Novartis Gene Therapies, Chicago, IL, USA

OBJECTIVES: To understand, from a payer and policymaker perspective, emerged trends and to identify insights on key priorities shaping the emerging trends in the Middle East and North Africa (MENA) countries.

METHODS: Based on a survey developed by the Professional Society for Health Economics and Outcomes Research (ISPOR) Arabic Network, data was collected from 40 representatives of the healthcare system of the MENA countries (Egypt, Jordan, Lebanon, Qatar, and Saudi Arabia). ISPOR Arabic Network chapters presidents selected their national participants in governmental and/or semi-governmental bodies responsible for pharmaceutical assessment for pricing and reimbursement decisions. The survey includes four sections. Follow-up e-mails were sent as reminders to non-responders.

RESULTS: A total of nine responses (22%) were received. Heterogeneity was observed in ranking top disease areas driving the trends emerging. The top three disease areas reported by countries surveyed are oncology, cardiology, and endocrinology. Rheumatology/immunology, infectious, renal diseases ranked high as well. Disease prevalence and medical and pharmacy budgets are the key drivers for the ranking by respondents. Health Data, Health Technology Assessment (HTA), and Need for New Business Model were identified as the most selected trends by all respondents (N=9), followed by Healthcare Financing, Public Health, and Value Assessment (N=8), Supply Chain, Staffing Shortages (N=7), Real World Evidence (N=6), Health Equity, Need for New Financing Models (N=5), Telemedicine (N=3), Focus on Rare Diseases, Patient Engagement (N=2), Artificial Intelligence (AI)/Internet of Things (N=1).

CONCLUSIONS: Significant regional variations in disease prevalence and impact on the healthcare budget were identified. Utilizing healthcare data, HTA, and the need for new business models were top trends while AI and patient engagement were the least. Further assessment on a larger scale will inform potential future collaborations on Regional initiatives.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

HPR159

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes, Public Spending & National Health Expenditures, Reimbursement & Access Policy

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×